Stanford, CA, United States of America

Xiaoyan Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoyan Zhao. Retrieved from https://idiyas.com/inventor/xiaoyan-zhao-x4pdewma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiaoyan Zhao

Introduction

Xiaoyan Zhao is an accomplished inventor based in Stanford, CA. He has made significant contributions to the field of medical diagnostics, particularly in the area of rheumatoid arthritis. His work focuses on improving the prognostic classification of patients, which can lead to more effective treatment strategies.

Latest Patents

Xiaoyan Zhao holds a patent titled "Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis." This patent provides compositions and methods for classifying rheumatoid arthritis disease patients into subtypes. These subtypes are crucial for determining the patient's need for therapy and their responsiveness to specific treatments. He has 1 patent to his name.

Career Highlights

Zhao is affiliated with Leland Stanford Junior University, where he conducts research and develops innovative solutions in the medical field. His work has the potential to significantly impact the way rheumatoid arthritis is diagnosed and treated.

Collaborations

Xiaoyan Zhao has collaborated with notable colleagues, including William H. Robinson and Peggy Pui-Kay Ho. Their combined expertise enhances the research and development efforts in their respective fields.

Conclusion

Xiaoyan Zhao's contributions to medical diagnostics, particularly in rheumatoid arthritis, showcase his innovative spirit and dedication to improving patient care. His work continues to pave the way for advancements in therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…